Total Funding
1
Total FundingSeries B raised
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
683918
Momentum Bioscience develops enzyme mediated amplification solutions for the rapid detection of pathogens in blood and sterile fluids.
Matthew Crow: Head of R&D
Sumi Thaker: CEO
About the Company
Momentum Bioscience Ltd has a novel and innovative approach for the detection of infection in blood and other normally sterile body fluids. There Enzyme Mediated Amplification technology allows universal detection of viable bacteria and fungi in <2 hours vs 1-5 days with current laboratory techniques. It is the only rapid technology available
that specifically measures viable organisms
Momentum Bioscience Ltd is developing a suite of related technologies collectively termed Enzyme Mediated Amplification (EMA), for the rapid detection of pathogens found in blood and normally sterile fluids (NSF).
